SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
60 hedge funds and large institutions have $21.6M invested in Sienna Biopharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
60
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$358K | |
| 2 | +$275K | |
| 3 | +$154K | |
| 4 |
Two Sigma Investments
New York
|
+$149K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$118K |
Top Sellers
| 1 | -$7.55M | |
| 2 | -$997K | |
| 3 | -$583K | |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$248K |
| 5 |
CAG
Crestwood Advisors Group
Boston,
Massachusetts
|
-$219K |